...
首页> 外文期刊>Diabetologia >The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study
【24h】

The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study

机译:弗雷明汉和英国前瞻性糖尿病研究(UKPDS)风险方程无法可靠地估计大量不同种族的糖尿病患者样本中心血管事件的可能性:糖尿病和血管疾病的作用:TERTERAX和Diamicron-MR对照评估(ADVANCE)研究

获取原文
获取原文并翻译 | 示例

摘要

Aims/hypothesis Available multivariable equations for cardiovascular risk assessment in people with diabetes have been derived either from the general population or from populations with diabetes. Their utility and comparative performance in a contemporary group of patients with type 2 diabetes are not well established. The aim of this study was to evaluate the performance of the Framingham and UK Prospective Diabetes Study (UKPDS) risk equations in participants who took part in the Action in Diabetes and Vascular disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) trial.
机译:目的/假设糖尿病患者可用于心血管风险评估的多变量方程式是从普通人群或糖尿病人群中得出的。它们在当代2型糖尿病患者中的效用和比较性能尚未得到很好的确定。这项研究的目的是评估参加糖尿病和血管疾病行动的参与者的弗雷明汉和英国前瞻性糖尿病研究(UKPDS)风险方程的表现:前畸形和Diamicron-MR对照评估(ADVANCE)试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号